<DOC>
	<DOCNO>NCT00578955</DOCNO>
	<brief_summary>The purpose study determine AzaSite Plus effective safe treatment blepharoconjunctivitis compare AzaSite alone Dexamethasone alone .</brief_summary>
	<brief_title>Comparative Study AzaSite Plus Compared AzaSite Alone Dexamethasone Alone Treat Subjects With Blepharoconjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Have clinical diagnosis blepharoconjunctivitis Must willing discontinue contact lens wear duration study Additional inclusion criterion also apply . Have know sensitivity poor tolerance component study medication . Have clinically significant cardiovascular disorder Have history liver kidney disease result persist dysfunction Have prior ( within 30 day begin study treatment ) anticipate concurrent use investigational drug device . Additional exclusion criterion also apply .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Blepharoconjunctivitis , Ophthalmology</keyword>
</DOC>